Spotlight On 3 Promising Penny Stocks With Market Caps Over $60M
As the U.S. stock market navigates mixed signals with the S&P 500 and Dow Jones aiming to extend their winning streaks, investors are keenly observing how broader economic factors like interest rates and tariffs might impact future growth. For those willing to explore beyond established giants, penny stocks—often representing smaller or newer companies—continue to hold relevance despite their somewhat outdated moniker. These stocks can offer surprising value when backed by strong financials, presenting a blend of potential value and growth that larger firms may overlook.
Name
Share Price
Market Cap
Financial Health Rating
Safe Bulkers (NYSE:SB)
$3.45
$361.71M
★★★★☆☆
Tuya (NYSE:TUYA)
$2.39
$1.44B
★★★★★★
Perfect (NYSE:PERF)
$1.86
$189.44M
★★★★★★
Smith Micro Software (NasdaqCM:SMSI)
$1.05
$18.66M
★★★★☆☆
Kiora Pharmaceuticals (NasdaqCM:KPRX)
$3.315
$9.95M
★★★★★★
Flexible Solutions International (NYSEAM:FSI)
$3.65
$46.16M
★★★★★★
Imperial Petroleum (NasdaqCM:IMPP)
$2.56
$77.65M
★★★★★★
BAB (OTCPK:BABB)
$0.8294
$6.02M
★★★★★★
Lifetime Brands (NasdaqGS:LCUT)
$3.594
$80.24M
★★★★★☆
CBAK Energy Technology (NasdaqCM:CBAT)
$0.7957
$71.73M
★★★★★☆
Click here to see the full list of 748 stocks from our US Penny Stocks screener.
Underneath we present a selection of stocks filtered out by our screen.
Simply Wall St Financial Health Rating: ★★★★★☆
Overview: Allied Gaming & Entertainment Inc., along with its subsidiaries, operates globally as a public esports and entertainment company with a market cap of $64.39 million.
Operations: Allied Gaming & Entertainment Inc. does not report specific revenue segments.
Market Cap: $64.39M
Allied Gaming & Entertainment Inc., with a market cap of US$64.39 million, operates in the esports and entertainment sector but remains pre-revenue. The company has more cash than debt and a sufficient cash runway for over three years based on current free cash flow trends. However, it faces challenges with compliance as it received a Nasdaq deficiency letter due to delayed SEC filings, which could impact its listing status if not resolved by June 2025. Despite these hurdles, management's experience and efforts to regain compliance may provide some stability amidst its unprofitable status and increased debt-to-equity ratio over recent years.
Jump into the full analysis health report here for a deeper understanding of Allied Gaming & Entertainment.
Examine Allied Gaming & Entertainment's past performance report to understand how it has performed in prior years.
Simply Wall St Financial Health Rating: ★★★★☆☆
Overview: The Beauty Health Company, along with its subsidiaries, engages in the design, development, manufacturing, marketing, and sale of aesthetic technologies and products across the Americas, Asia-Pacific, Europe, the Middle East, and Africa with a market cap of $143.63 million.
Operations: The company's revenue is primarily generated from its Personal Products segment, totaling $334.29 million.
Market Cap: $143.63M
Beauty Health, with a market cap of US$143.63 million, has shown improvement by reducing its net loss from US$100.1 million to US$29.1 million over the past year, despite remaining unprofitable. The company's revenue for 2024 was US$334.29 million, down from the previous year, and it forecasts further declines in sales for 2025 to between US$270 million and US$300 million. Although its short-term assets cover liabilities comfortably, long-term liabilities remain uncovered by current assets. Leadership changes include Mr. Ronald Menezes becoming an executive officer as part of efforts to stabilize operations amidst ongoing volatility and high debt levels.
Click to explore a detailed breakdown of our findings in Beauty Health's financial health report.
Examine Beauty Health's earnings growth report to understand how analysts expect it to perform.
Simply Wall St Financial Health Rating: ★★★★★☆
Overview: GoodRx Holdings, Inc. operates by providing consumers in the United States with information and tools to compare prices and save on prescription drug purchases, with a market cap of approximately $1.80 billion.
Operations: The company's revenue is primarily derived from its Healthcare Software segment, which generated $792.32 million.
Market Cap: $1.8B
GoodRx Holdings, with a market cap of US$1.80 billion, is actively leveraging digital innovation to enhance its prescription purchasing process. The recent launch of an e-commerce experience with Hy-Vee aims to streamline medication access and improve pharmacy efficiency. Financially, GoodRx reported 2024 revenue of US$792.32 million and transitioned to profitability with a net income of US$16.39 million from a previous loss. While short-term assets exceed liabilities significantly, interest coverage remains slightly below optimal levels at 2.9x EBIT coverage, despite satisfactory debt management and experienced leadership poised for strategic growth initiatives in the healthcare sector.
Take a closer look at GoodRx Holdings' potential here in our financial health report.
Learn about GoodRx Holdings' future growth trajectory here.
Dive into all 748 of the US Penny Stocks we have identified here.
Ready For A Different Approach? Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include NasdaqCM:AGAE NasdaqCM:SKIN and NasdaqGS:GDRX.
This article was originally published by Simply Wall St.
Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@simplywallst.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
42 minutes ago
- Yahoo
Apple's two biggest problem areas ahead of its WWDC 2025
Ahead of Apple's (AAPL) 2025 Worldwide Developers Conference kicking off this Monday, June 9, Needham analysts downgraded the iPhone maker from a Buy rating to Hold while removing its price target on the tech stock. Needham & Company senior media and internet analyst Laura Martin — the analyst behind the call — examines several of Apple's biggest problems as it faces pressures in China's consumer market and the team-up between OpenAI and former Apple designer Jony Ive. Here's a look at what to expect from the 2025 WWDC event. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here. Let's take a look at Apple here. It's down 19% year to date, the lowest performing member of the magnificent seven and trailing the S&P 500, which is now up for the year. Ahead of Apple's company, uh, Worldwide Developers Conference, Needham and company cut its Apple rating from buy to hold and removed its $225 price target for the stock. We've got the person behind that call, Laura Martin, Needham and Company senior media and internet analyst joining us now. Really appreciate you making the time to break this down for us, Laura. What was the single biggest driver behind this call on Apple? So I think, I think we're focusing on two things. There's like an urgent problem for Apple and then an important problem for Apple. The urgent problem is, a, it's really expensive today at 26 times next year's earnings, which is twice its normal multiple over the last 10 years, and about a 25% premium to the S&P 500. So it's too expensive. Second, there are real risks to their fundamentals over the next 12 months. Not only tariffs, but, um, but also like the Chinese demand, which used to be 19% of their total iPhone sales, went to 17% last year. We expect it to go to 15% of total sales this year. So there, um, there really is issues with the rising nationalism in China and Chinese, uh, consumers buying competitive products and not Apple products. Um, also, we have risk of fundamentals services revenue because you may have seen that epic, uh, the epic court decision, which allows all these apps to actually get direct payment and not pay the Apple 30% tithe on, on these app payments. So that actually threatens services revenue. Anyway, lots of fundamental risks, um, coming from the outside world in the near term, again, to their fundamental earnings per share, a risk in addition to just tariffs. And the important problem here that isn't as urgent, but it is really important is competition. So what's happening is generative AI is opening up the possibility of replacing the smartphone with, if you think meta and Google are right, glasses, like these Ray-Ban glasses that Meta's already sold a million units of. Or, more importantly, um, Jony Ive, who used to was actually the designer behind every major Apple product on the market today, he was at Apple for 27 years, has recently, his company's been bought by Sam Altman's OpenAI, and they're talking about a new form factor that isn't a smartphone and it isn't glasses, but it's going to compete and replace, I mean, I think over the long term replace the iPhone because Jony Ive, who invented the iPhone as a design fact, uh, hardware, said he doesn't like screens. He wants to move consumers away from screens, which would be lovely if you could have a conversation with a 15-year-old where they weren't looking at their screens. So I'm completely supportive, but all of this is a competitive is a competitive threat to the largest iPhone maker, you know, the largest smartphone maker in the world. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
CNBC
an hour ago
- CNBC
Two aerospace stocks are deeply overbought and could be due for a pullback
GE Aerospace and Howmet Aerospace are vulnerable to pullbacks after entering deep overbought territory this week. Each stock climbed more than 3% this week, outperforming the S & P 500 's 1.5% gain in the same period. The stocks have come so far so fast that now GE Aerospace and Howmet have the two highest 14-day relative strength index, or RSI, readings in the S & P 500. CNBC Pro used its stock screener tool available for subscribers to find the most oversold stocks as measured by the 14-day RSI. Stocks that have a 14-day RSI above 70 are viewed as overbought, leaving them susceptible to a decline, while those a 14-day RSI below 30 are often thought of as oversold, suggesting they may see a bounce. GE Aerospace has now risen for nine straight weeks, while Howmet has advanced for seven. GE Aerospace is ahead more than 53% year to date, while Howmet is up more than 60%. While the typical analyst polled by LSEG has buy ratings on both companies, the consensus 12-month price target foresees more than 5% downside for each stock over the next year following these big runs. Here's the full list of S & P 500 stocks with the highest 14-day RSIs, along with what Wall Street thinks of them, according to LSEG data as of Friday morning: At the other extreme, Brown-Forman is the most oversold name in the S & P 500 with a 14-day RSI below 22. Shares of the Jack Daniel's whiskey distiller tumbled nearly 16% this week. Much of the decline came after Brown-Forman posted revenue and net income for its fiscal fourth quarter that missed analysts' consensus forecasts, according to consensus LSEG numbers. The Louisville-based company said it was operating in an "exceptionally challenging macroeconomic environment." The stocks has slumped 37% in the past six months and is on pace to record its fifth consecutive down year. Although Wall Street analysts rate Brown-Forman no more than a collective "hold," the consensus 12-month price target as compiled by LSEG suggests shares may rally 35%. Brown-Forman also has a dividend yield of 3.32%. Here are the other stocks with 14-day RSIs below 30, along with what Wall Street sees for them:
CNN
an hour ago
- CNN
Should you invest in crypto now?
Much has changed in the crypto landscape over the past year and a half. And with it, so may more investors' minds about cryptocurrencies — especially bitcoin, the (very young) granddaddy of them all. Crucially, crypto has gained greater acceptance among regulators and large institutional investors as an asset class that is likely here to stay. The Securities and Exchange Commission now regulates spot bitcoin and ethereum exchange-traded funds. Coinbase, the crypto currency exchange, is now on the S&P 500. Stablecoin provider Circle just went public. The Trump administration, meanwhile, is very supportive of crypto, and the Labor Department just rescinded its 2022 guidance urging 401(k) fiduciaries to 'exercise extreme care' if they include a crypto investment option to plan participants. With bitcoin now trading above $100,000 and US lawmakers actively working on crypto regulations, it may be worth revisiting the question of whether you should have exposure in your portfolio. The answer will be highly personal, driven by your risk tolerance, time horizon and knowledge. Despite being a crypto advocate, Tyrone Ross, founder of financial planning firm 401 Financial, put it this way: 'We have a long way to go before you should be YOLO-ing your way into crypto.' When financial advisers have been asked over the past several years whether they would recommend that clients invest in bitcoin or other cryptocurrencies, many were reluctant because digital assets were not regulated, pricing was highly volatile and their use case and valuation was hard for both adviser and client to understand. Unlike stocks, which can be valued on the basis of tangible components such a company's goods and services, bitcoin is considered a store of value, and its price is driven by what others are willing to pay for it. That caution was understandable, said Ric Edelman, who founded Edelman Financial Engines and then created the Digital Assets Council of Financial Professionals, which provides certification courses in blockchain and digital assets for financial professionals and investors. But, at this point, Edelman believes that advisers who value diversification as a strategy in their clients' portfolio — eg, across asset classes, sectors, etc. — would be remiss not to recommend adding at least a small amount of digital asset exposure. 'They ought to be cautious. But being cautious doesn't mean abstinence,' he noted. 'We've seen bitcoin reach all-time highs and seen institutional investors engage for the first time.' Several years ago, when crypto's future was far less certain, Edelman had recommended a 1% asset allocation to crypto, an amount small enough that even if a crypto investment fell to zero it would not greatly harm the long-term trajectory of a person's portfolio. In March this year, using bitcoin as an example, he compared the performance of a balanced 60% stocks/40% bonds portfolio with an average annual return of 7% over a decade, to a portfolio where the equity portion is reduced to 59% in favor of a 1% investment in bitcoin. In the extreme, if bitcoin became worthless the average return would only drop to 6.9%. And, equally extreme, if the price rose to $1 million, the return would increase to 7.4%. If the equity portion were reduced to 57% with 3% put into bitcoin, the average return drops to 6.8% in the worthless scenario and jumps to 8.2% if bitcoin hits $1 million. If bitcoin exposure were upped to 5%, the downside return would be 6.7% and the upside return would be 9%. Despite bitcoin trading around $100,000 — a nosebleed level relative to where it had fallen during the so-called crypto winter of 2022 — Edelman believes that the price still has a lot of upward potential because the number of bitcoins is permanently limited and demand for it is increasing. For those who have yet to invest in crypto and would like to, 'the best place to begin is bitcoin,' Edelman said. 'It is by the far the largest digital asset — and it's the digital asset of choice for institutional investors.' And, he added, 'it's different than all other digital assets. It's a store of value and a transmittal (instrument). All the others are designed for specific commercial uses and it's far less certain as to which of the others will be successful.' But investing directly in bitcoin and storing it in your own wallet can be a complicated proposition unless you know what you're doing. 'Scams are a big issue in this space,' Ross said. A far safer route for the novice crypto investor, he and Edelman said, is through an SEC-regulated bitcoin ETF. Not everyone is as immediately bullish as Edelman. In a March note to clients, TIAA chief investment officer Niladri Mukherjee said, 'While broadening enthusiasm around crypto adoption and the bitcoin ETFs are an encouraging sign for the industry, from an investment perspective, its value drivers will take time to develop and to be well understood by market participants.' Given that the industry is still 'quite opaque and unregulated,' Mukherjee added that individuals should do their due diligence before investing. But even before you do that, gut check yourself. When asked who absolutely should not invest in crypto, Edelman was quick to reply: 'Those who cannot emotionally tolerate volatility. Because we know (cryptocurrencies are) highly volatile. You're likely to sell when prices are low.' That's especially the case if you decide to invest directly in a given coin. A good way to test your appetite for volatility is to consider how much you might spend on a nice meal at a favorite restaurant and invest that amount into crypto if it doesn't strain your household budget. Then just watch to see what happens over the next several months, Ross said. 'Track it, read about it, understand its ebbs and flows.' In other words, educate yourself about how things work before making any real commitment to it. Then if you think you're comfortable enough, you might invest small amounts monthly — again, nothing that would compromise you financially, he suggested. In terms of an overall allocation of your assets, Lazetta Rainey Braxton, founder of the financial planning firm The Real Wealth Coterie, said you want an amount that is small enough that it won't undermine the valuation of your portfolio if things go south. And, she added, '(stick) with players that are well known and respected and have the infrastructure in place to make sure that they are offering a solid investment and also the information associated with that.' Trent Porter, a certified financial planner and certified public accountant at Priority Financial Partners, is not a big fan of crypto even with all the developments in recent months easing investment in the space. 'My core advice remains unchanged: Crypto exposure should match an investor's personal risk tolerance and capacity, keeping the allocation small (no more than 5%) for most people. Regulatory risk might have eased, but market risk is still very real, and as we all know, the regulatory environment can change quickly.'
